is fda banning compounded semaglutide "semaglutide" not FDA-approved US judge upholds FDA's removal

Suppliers who cannot answer basic technical questions about their products, such as the synthesis method, purification approach, or storage recommendations, likely do not manufacture or even properly source what they sell

Baral KC, Choi KY

Table 1 illustrates that the most significant obstacles to progress across these systems have not been a lack of physiological relevance, but unresolved pharmacologic, technological, or conceptual challenges

We use strictly low-temperature processed protein to source Level-1. This is a method to ensure the delicate protein fractions remain intact, which can help support and preserve the bioavailability and unique functional properties of the protein